Protective Effect of Thiamine Pyrophosphate Against Capecitabine-Induced Liver Injury in Rats

Background: Hepatotoxicity is an adverse effect that may limit the clinical use of capecitabine (CAP). The present study compared the protective effects of thiamine pyrophosphate (TPP) and thiamine against CAP-induced liver injury in rats. Methods: Twenty-four albino Wistar rats were randomly assigned to four groups (n = 6 per group): healthy control (HG), CAP-treated (CP), TPP + CAP (TPCP), and thiamine + CAP (TCP). The TCP and TPCP groups received thiamine and TPP (20 mg/kg, intraperitoneally), respectively, while the HG and CP groups received 0.9% sodium chloride (NaCl) by oral gavage. Treatments were administered daily, and CAP (200 mg/kg, orally) was given 5 days weekly for 28 days. Hepatic oxidative stress and inflammatory markers, along with serum Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) activities, were measured. Histopathological injury and the immunoreactivities of cytokines and 8-hydroxy-2′-deoxyguanosine (8-OHdG) were also evaluated. Results: Compared with HG, CAP increased hepatic MDA and proinflammatory cytokine levels and serum ALT and AST activities, while decreasing tGSH, SOD, and CAT levels (all p < 0.001). TPP attenuated these biochemical alterations more effectively than thiamine (p < 0.001). TPP and thiamine reduced necrosis and hydropic degeneration, and decreased IL-1β, IL-6, TNF-α, and 8-OHdG immunopositivity compared with the CP group (p < 0.001). TPP reduced hepatic immunopositivity more effectively than thiamine (p < 0.001). Conclusions: Under the tested dosing conditions, TPP provided greater hepatoprotection than thiamine against CAP-induced liver injury in rats; however, further studies are needed to establish its clinical relevance.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-19
DOI
https://doi.org/10.3390/ph19111843
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Protective Effect of Thiamine Pyrophosphate Against Capecitabine-Induced Liver Injury in Rats

Meryem Yalvac Kandefer, Zeynep Süleyman, Seval Bulut, Halis Süleyman et al.
Pharmaceuticals
Drug-Induced Hepatotoxicity and Protection
article

Protective Effect of Thiamine Pyrophosphate Against Capecitabine-Induced Liver Injury in Rats

Meryem Yalvac Kandefer, Zeynep Süleyman, Seval Bulut, Halis Süleyman, Mustafa Özkaraca, Behzad Mokhtare, Taha Abdulkadir Çoban
article en

Abstract

Background: Hepatotoxicity is an adverse effect that may limit the clinical use of capecitabine (CAP). The present study compared the protective effects of thiamine pyrophosphate (TPP) and thiamine against CAP-induced liver injury in rats. Methods: Twenty-four albino Wistar rats were randomly assigned to four groups (n = 6 per group): healthy control (HG), CAP-treated (CP), TPP + CAP (TPCP), and thiamine + CAP (TCP). The TCP and TPCP groups received thiamine and TPP (20 mg/kg, intraperitoneally), respectively, while the HG and CP groups received 0.9% sodium chloride (NaCl) by oral gavage. Treatments were administered daily, and CAP (200 mg/kg, orally) was given 5 days weekly for 28 days. Hepatic oxidative stress and inflammatory markers, along with serum Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) activities, were measured. Histopathological injury and the immunoreactivities of cytokines and 8-hydroxy-2′-deoxyguanosine (8-OHdG) were also evaluated. Results: Compared with HG, CAP increased hepatic MDA and proinflammatory cytokine levels and serum ALT and AST activities, while decreasing tGSH, SOD, and CAT levels (all p < 0.001). TPP attenuated these biochemical alterations more effectively than thiamine (p < 0.001). TPP and thiamine reduced necrosis and hydropic degeneration, and decreased IL-1β, IL-6, TNF-α, and 8-OHdG immunopositivity compared with the CP group (p < 0.001). TPP reduced hepatic immunopositivity more effectively than thiamine (p < 0.001). Conclusions: Under the tested dosing conditions, TPP provided greater hepatoprotection than thiamine against CAP-induced liver injury in rats; however, further studies are needed to establish its clinical relevance.

PharmaceuticalsVol. 19(11)
Dicle University (TR), Sivas Cumhuriyet Üniversitesi (TR), Erzincan Binali Yıldırım University (TR)
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon